News Center

Home page

Peak Report

News reports

We go to the audit

Release time:

2020-07-22

We went to audit

# May 17 -19 . As a member of the supplier audit team, I visited Changzhou Ruiming, Wuxi Yangjian Huaqiang, Suzhou Haishun, Zhejiang Duoling Pharmaceutical Packaging and other companies with my colleagues and conducted a series of audit work.

As one of the key elements of production, the quality and stability of raw materials and auxiliary materials directly determine the stability of the final product quality. In order to ensure the stability of product quality, our manufacturers conduct supplier audits of raw and auxiliary package suppliers every year. This is an on-site audit, including verifying the authenticity of the supplier's qualification documents and inspection reports, whether they have inspection conditions, etc., as well as reviewing its personnel structure, plant facilities and equipment, material management, production process and production management, and quality control laboratory equipment, instruments, document management, etc.

This is my first time to participate in the audit, although I made a corresponding inspection plan for the basic situation of all the suppliers to be inspected before departure. However, once you arrive at the scene, you will still be nervous and do not know where to start. With the warm reception of the representatives of the supply side, our audit work was carried out in an orderly manner.

First of all, we went to the manufacturers of raw materials and chemical raw materials. Before entering the production area, the reception staff of the other party gave us full oral safety education and issued safety helmets, demonstrating the safety awareness that a chemical plant should have. Their production area and office area have obvious regional isolation, effectively avoid cross-contamination. However, some parts of the production site are not doing very well. For example, the unloading position of the raw materials delivered from the warehouse is too random, which is just the place where solar energy is exposed. The label of the raw materials during feeding was removed in advance. In contrast, our factory has done a better job of on-site management. When the raw materials come, there will also be a special unloading position. The labels of the materials will be on the materials until the end of feeding, so as to avoid confusion. We raised these issues with the manufacturer, and the other party accepted them modestly, dealt with them in a timely manner, and said that they would provide rectification reports after all rectifications.

may be an old customer. The manufacturers of composite film (bag) and aluminum foil for drug packaging are a little too casual in reception. We arrived at the factory on the same day but could not find the reception staff. On the spot, there is a sharp contrast between the packaging material manufacturers and our pharmaceutical companies. Although they are also in the D area, their spot is slightly messy and their concept of clearing the spot is somewhat vague. Due to continuous production, the equipment site is easy to leave materials, and the lack of fixed position is slightly messy. They also made rectification immediately after the site was put forward. For our pharmaceutical factory, it is also necessary to change what we have and encourage what we have not.

The third enterprise we went to is a large listed company. Not only can the production and inspection equipment meet the production and inspection requirements, but also the production line is fully automatic production of industry 4.0 , which is fully automated from equipment operation, material and product transportation. In the workshop, the quality of products is also monitored in real time through the central control room, and the positioning of various items is also standardized. The warehouse is a 4 -storey three-dimensional library, which realizes unmanned operation. Their laboratory even has a separate aluminum plastic machine to do challenging experiments, reflecting their pursuit of product quality excellence. All these are worth learning. The wave of industrial automation upgrading is constantly advancing. Although we have not yet entered that stage, we must always maintain our own improvement to meet this wave.

The last company is an enterprise that produces PVC medicinal hard tablets and various composite hard tablets and composite high-barrier packaging materials. Our host is their QC supervisor. To my surprise, their supervisor QC was born in a health school and took part in the inspection work, but he was quite familiar with their process flow and process parameters. This also makes us realize that no matter what position we are in, we should actively learn what we can come into contact with, especially for the process flow and process parameters in production, showing a kind of professionalism for our own industry. During the audit, we found that their workshop also has a special access to visit, each door has access control, for access control is very good. This is where we can learn from. For a workshop, access control is very important, which can effectively avoid problems such as personnel stringing and pollution.

As a production enterprise, our pharmaceutical factory also accepts the audit of our customers every year. Through this rare audit opportunity, I can look at the supplier from the customer's point of view, from which I can objectively see many problems in daily work and production. The first point is that for the reception of customers, special personnel and sufficient relevant information can make customers have a good impression on us; on the production site, various small details determine the quality of the product and whether the production process meets the customer's standards; records and various inspection reports show the true quality of the product. Taking the essence and removing the dross, we will apply the experience gained during this audit to our daily production work, which will certainly give a great impetus to our future work. (Zheng Nan)

More information

Two Cement Enterprises Prosperous Production and Sales in May

With the gradual easing of the new crown epidemic, all over the project has started, Hubei, Yunnan two provinces cement market continued to improve, Daye peak cement company, Yunnan peak cement company two enterprises have recently shown a good momentum of production and sales. In May, the sales volume of Yunnan Jianfeng cement continued to rise. As of the time of publication, the average daily shipment volume reached more than 7400 tons, and the highest daily shipment volume reached more than 8700 tons, and the production capacity was fully released. Over the past few days, Yunnan Peak Packaging System has made great efforts to overcome the impact of narrow distribution sites and many cement varieties to ensure the completion of delivery tasks with good quality and quantity every day. In order to further balance production and sales and create conditions for the homogenization of cement delivered from the factory, Yunnan peak packaging system puts forward work requirements for relevant posts, emphasizes equipment inspection and process inspection during production, strictly implements safety operation procedures, and maintains safe and efficient operation of the system. Due to the impact of the new crown epidemic, Hubei cement market started late, Wuhan market is the hardest hit area, the current project construction is still not fully started, the volume pressure is greater. For this reason, daye peak departments cooperate closely, increase market development efforts, develop new mixing stations, focus on increasing the bulk share of Xianning, Huanggang and Wuhan markets, seize the opportunity of fine weather, and achieve the goal of rapid output. Internally, on the basis of equipment technical renovation and production capacity improvement, the delivery is effectively guaranteed, and the daily delivery capacity can basically be maintained at 10,000 tons. In May, Daye Peak sold more than 300000 tons of cement, an increase of 20% over the same period last year, with an average daily sales volume of more than 9900 tons, the highest in the current period since Daye Peak was put into production.

2020

07-31

The company's "safe production month" activities are about to start

June 2020 is the 19th national "safe production month", the theme of the activity is "eliminating hidden dangers of accidents and building a strong line of defense". A few days ago, the group company issued a notice to arrange the activities related to the organization of "safe production month" and put forward requirements. According to the group's "safe production month" activity plan, different key thematic activities will be held in the four weeks of June. The first week is the "Publicity and Safety Education Week", which focuses on the use of WeChat groups, electronic screens, publicity boards, banners, slogans and other forms for safety publicity, and organizes the study of national safety regulations, company safety system specifications and accident-free factory creation standards, Organize to watch safety warning education films, learn accident cases, etc., and improve employees' safety awareness by creating a safety atmosphere and organizing learning activities. The focus of the activities in the second week is "looking for potential sources of danger around you". Each unit takes departments and teams as units to investigate and analyze the potential risk factors in the process of daily production, maintenance and operation, find out the hazard sources that have not been included in the scope of risk point control, and report to the safety management department of the unit to form a risk assessment report, put forward solutions or suggestions, and supervise the implementation of rectification and timely eliminate potential safety hazards. The third week is the "on-site safety innovation achievements exhibition week", which focuses on the achievements of each unit in on-site safety management and on-site safety facilities in the past year, which are displayed in the form of pictures and texts through beautiful articles and wechat, so as to learn from each other and promote common progress. The fourth week is the "safety training and drill week", and the group company organizes the standardization of safety production and the elimination of hidden dangers.

2020

07-31

Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua

News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.

2020

07-31

Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua

2020

07-30

Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua

2020

07-22

The 14th meeting of the 10th board of directors and the 9th meeting of the 9th board of supervisors held to review and approve the annual work report and other relevant proposals

On April 24, Jiang Xiaomeng, chairman of the group company, presided over the 14th meeting of the 10th board of directors of the company, and deliberated and passed 14 related reports and motions such as the 2019 annual board of directors report, the 2019 general manager business report and the 2019 annual report. The general manager's report pointed out that 2019 is the first year of the implementation of the group's new five-year strategic development plan (2019-2023) and the new three-year business plan (2019-2021) for each business sector. the management team has carried out various operation and management work in an orderly manner around the general policy of "innovation and reform, integration and promotion, scientific layout and steady development", and has better completed the business objectives set by the board of directors at the beginning of the year. In the whole year, the company achieved a total operating income of 3.548 billion billion yuan, an increase of 5.51 percent over the same period last year; net profit attributable to shareholders was 0.725 billion billion yuan, with earnings per share reaching 2.11 billion yuan, an increase of 23.14 percent over the same period last year, a record high; total assets at the end of the year were 5.475 billion billion yuan, an increase of 11.71 percent over the same period last year; and net assets attributable to shareholders were 3.789 billion billion yuan, an increase of 19.81 percent. During the reporting period, the company's two main businesses have achieved great development, benefiting from the further promotion of supply-side structural reform, the overall operation of the cement industry in 2019 is stable, and the industry benefits are further improved. During the reporting period, the company made new progress in the construction of cement projects, completed the acquisition, capital increase and name change of Guizhou Mingchuan (Guizhou Huangping Jianfeng Cement Co., Ltd.), and continued to invest in the construction of its new dry cement production line with a daily output of 4500 tons of clinker.

2020

07-31

< 1...23 24 25...61 > 跳转到页